Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Receivables: 2019-2024

Historic Receivables for CureVac N.V (CVAC) over the last 6 years, with Dec 2024 value amounting to $18.0 million.

  • CureVac N.V's Receivables fell 98.21% to $462,971 in Q2 2025 from the same period last year, while for Jun 2025 it was $29.0 million, marking a year-over-year decrease of 59.96%. This contributed to the annual value of $18.0 million for FY2024, which is 11.12% up from last year.
  • Latest data reveals that CureVac N.V reported Receivables of $18.0 million as of FY2024, which was up 11.12% from $16.2 million recorded in FY2023.
  • Over the past 5 years, CureVac N.V's Receivables peaked at $24.3 million during FY2021, and registered a low of $3.8 million during FY2020.
  • Over the past 3 years, CureVac N.V's median Receivables value was $16.2 million (recorded in 2023), while the average stood at $14.4 million.
  • In the last 5 years, CureVac N.V's Receivables plummeted by 78.01% in 2020 and then surged by 535.51% in 2021.
  • Over the past 5 years, CureVac N.V's Receivables (Yearly) stood at $3.8 million in 2020, then skyrocketed by 535.51% to $24.3 million in 2021, then tumbled by 62.81% to $9.0 million in 2022, then soared by 79.44% to $16.2 million in 2023, then climbed by 11.12% to $18.0 million in 2024.